Register Log-in Investor Type

Worldwide Healthcare : WWH – final results

Worldwide Healthcare has published its results for the year that ended 31 March 2014. Over the period the fund’s net asset value generated a total return of 25.9%. The fund’s rating improved, driving the total return to shareholders for the period up to 30.8%. The MSCI World Healthcare Index delivered a return of 14.9% over the same period. The dividend was reduced from 16.5p to 15.0p.

The report mentions contributions from Incyte, Intermmune and Gilead Sciences – which are all biotech companies – from genomic research company, Illumina, and from MAKO Surgical – as M&A activity continued in the sector.

Leave a Reply

Your email address will not be published. Required fields are marked *

Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.

You live in…

You are a…